Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Ricerca:      Estesa  
    
Foto
NomeViviana De Rosa
AreaRicerca e Sviluppo
QualificaRicercatore
SedeNapoli-De Amicis
IndirizzoVia De Amicis 95, 80145 Napoli - Italia
E-mailviviana.derosaibb.cnr.it
Telefono ufficio0039 081 2203430
    Malattie Neoplastiche
    Gadd45 beta and its implication in chronic inflammation
    Characterization of neurotoxic and neuroprotective factors by using computational methodologies
    Monoclonal Antibodies for therapeutic and diagnostic applications
    Targeted Drug Delivery by integrin avb3 antagonist
    Protein aggregation and cytotoxicity: molecular, in vitro and in vivo biological studies
    Metals role in angiogenesis
    Drug Delivery
    Bioactive peptide-membrane assemblies
    Metals and small molecules in the regulation of the Ubiquitin Proteasome Pathway
    Protein semi-synthesis for biophysical and chemical biology applications
    Peptide modulators of the VEGF-dependent angiogenesis
    Peptides promoting reverse cholesterol transport
    CA IX as target for the development of new anti-tumour drugs
    Carbonic Anhydrase family as target for rational drug design
    Clinical Oncology
    Translational Molecular Imaging in Cancer
    Molecular imaging for personalized therapy in oncology
    Modeling radiation induced normal tissue effects
    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Nucleic acid and protein binding studies
    Segmentazione cerebrale per applicazioni in radiologia oncologica
    Clinical Oncology
    Translational Molecular Imaging in Cancer
    Molecular imaging for personalized therapy in oncology
Curriculum vuoto

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]

Bibliografia

Ordina per:   data    titolo    rivista    autori    impact factor

* Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins (24 visite)
Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2018 Aug 9; 19(8): N/D-N/D.
Impact Factor: 3.687
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by (18)F-fluorothymidine (352 visite)
Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432print, 1078-0432linking), 2018 Jul 1; 24(13): 3126-3136.
Impact Factor: 10.199
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells (95 visite)
Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2017 Feb; 12(2): 1-15.
Impact Factor: 3.54
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors (101 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi CG, Fonti R, Del Vecchio S
Ejnmmi Res, 2016 Dec; 6(1): 74-74.
Impact Factor: 1.761
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Preclinical imaging in oncology: advances and perspectives (89 visite)
Iommelli F, De Rosa V, Terlizzi C, Del Vecchio S
Q J Nucl Med Mol Imaging (ISSN: 1827-1936electronic, 1824-4785linking), 2016 Nov 18; 61(1): 33-47.
Impact Factor: 2.481
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer (328 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432linking, 1078-0432electronic, 1078-0432print), 2015 Nov 15; 21(22): 5110-5120.
Impact Factor: 8.738
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC (97 visite)
Iommelli F, De Rosa V, Monti M, Panico M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib (123 visite)
Monti M, De Rosa V, Iommelli F, Fonti R, Pane F, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC (177 visite)
De Rosa V, Iommelli F, Monti M, Mainolfi C, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015 Oct; 42: N/D-N/D.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combination of Abeta Secretion and Oxidative Stress in an Alzheimer-Like Cell Line Leads to the Over-Expression of the Nucleotide Excision Repair Proteins DDB2 and XPC (111 visite)
Forestier A, Douki T, De Rosa V, Beal D, Rachidi W
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2015 Jul 30; 16(8): 17422-17444.
Impact Factor: 3.257
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation (101 visite)
De Rosa V, Iommelli F, Monti M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2014 Oct; 41: N/D-N/D.
Impact Factor: 5.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT (97 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Gramanzini M, Fonti R, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2014 Oct; 41: N/D-N/D.
Impact Factor: 5.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (185 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2014 Sep 15; 20(18): 4806-4815.
Impact Factor: 8.722
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer (124 visite)
Iommelli F, De Rosa V, Fonti R, Del Vecchio S
Clin Transl Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors (102 visite)
Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Ortosecco G, Greco A, Gramanzini M, Fonti R, Brunetti A, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) (96 visite)
De Rosa V, Iommelli F, Votta G, Monti M, Ortosecco G, Fonti R, Mainolfi C, Stoppelli M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? (160 visite)
Bera S, De Rosa V, Rachidi W, Diamond AM
Mutagenesismutagenesis (ISSN: 0267-8357, 1464-3804electronic, 0267-8357linking), 2013 Mar; 28(2): 127-134.
Impact Factor: 3.497
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Alzheimer's disease-associated neurotoxic peptide amyloid-beta impairs base excision repair in human neuroblastoma cells (118 visite)
Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2012 Nov 13; 13(11): 14766-14787.
Impact Factor: 2.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer (102 visite)
Zannetti A, Iommelli F, De Rosa V, Nardelli A, Ortosecco G, Del Vecchio S
European Journal Of Cancer (ISSN: 0959-8049), 2012 Nov; 48: N/D-N/D.
Impact Factor: 5.061
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors (109 visite)
Zannetti A, Iommelli F, De Rosa V, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells (105 visite)
De Rosa V, Erkekoǧlu P, Forestier A, Favier A, Hincal F, Diamond AM, Douki T, Rachidi W
Free Radic Res Free Radical Research (ISSN: 1071-5762), 2012; 46(2): 105-115.
Impact Factor: 3.279
Dettagli    Esporta in BibTeX    Esporta in EndNote

Selenium protects against the cytotoxic and genotoxic effects of oxidative stress both as an anti-oxidant and by stimulating DNA damage repair (77 visite)
Rachidi W, De Rosa V
Bulletin Du Cancer (ISSN: 0007-4551), 2011 Mar; 98: N/D-N/D.
Impact Factor: 0.672
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells (87 visite)
Erkekoǧlu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F
Free Radic Biol Med (ISSN: 0891-5849, 0891-5849linking, 1873-4596electronic), 2010 Aug 15; 49(4): 559-566.
Impact Factor: 5.707
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Effect of selenium on lethal and genotoxic properties of oxidative stress (74 visite)
De Rosa V, Diamond A, Favier A, Douki T, Rachidi W
Bulletin Du Cancer (ISSN: 0007-4551), 2010 Mar; 97: N/D-N/D.
Impact Factor: 0.887
Dettagli    Esporta in BibTeX    Esporta in EndNote

* The anticancer effect of selenium: study of its role in DNA repair activity and resistance to oxidative stress (79 visite)
De Rosa V, Alan D, Alain F, Thierry D, Walid R
Bulletin Du Cancer (ISSN: 0007-4551), 2009 Mar; 96: N/D-N/D.
Impact Factor: 0.792
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: Comparison with clinical and radiological evaluation (98 visite)
Maurea S, Acampa W, Varrella P,  De Rosa V, Fimiani P, Abate G, Salvatore M
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1998 May; 23(5): 283-290.
Impact Factor: 0.283
Dettagli    Esporta in BibTeX    Esporta in EndNote



26 Records (17 escludendo Abstract e Conferenze).
Impact factor totale: 107.952 (59.966 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 100.929 (55.78 escludendo Abstract e Conferenze).








Ultima modifica di Viviana De Rosa in data Tuesday 08 January 2019, 13:39:56
1558 visite. Ultima visita in data Tuesday 12 February 2019, 1:47:04

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Friday 15 February 2019, 13:06:47